We analyzed an HCC cohort and consistently found that patients with high MUC1 levels were prone to worse overall survival (P = 0.0305), metastasis-free survival (P = 0.0349), and lung metastasis-free survival (P = 0.0325) (Fig. 1c). The gene discussed is MUC1; the disease is hepatocellular carcinoma.